# OnCo record epic-seq (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/epic-seq/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "epic-seq" ;
  schema:name "EPIC-seq (expression inference from cell-free DNA)"@en ;
  schema:alternateName "EPIC-seq"@en, "Epigenetic expression inference from cell-free DNA-sequencing"@en ;
  schema:description "A blood test method that infers which genes a tumour is using from how DNA fragments are cut at the start of each gene."@en ;
  schema:url <https://onco.cc/technologies/epic-seq/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41587-022-01222-4> ;
  onco:status "emerging" ;
  onco:related <https://onco.cc/technologies/griffin-nucleosome-profiling/>, <https://onco.cc/technologies/plasma-epigenomic-profiling/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/fragmentomics/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:terms <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/ctdna/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-subclone-attribution-residual-disease/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-esfahani-epic-seq-nat-biotechnol-2022/> .